search

opensafely / antibody-and-antiviral-deployment

While vaccines remain the best strategy to prevent COVID-19, mAbs could potentially benefit certain vulnerable populations before or after exposure to SARS-CoV-2, such as the unvaccinated or recently vaccinated high-risk patients.
MIT License
1 stars 4 forks source link

issues

Newest
Newest Most commented Recently updated Oldest Least commented Least recently updated